Literature DB >> 29291226

Role of circulatory microRNAs in the pathogenesis of hepatitis C virus.

Iqra Almas1, Samia Afzal1, Muhammad Idrees1,2, Muhammad Usman Ashraf1, Iram Amin1, Muhammad Shahid1, Khadija Zahid1, Sadia Zahid1.   

Abstract

Hepatitis C virus (HCV) is associated with one of the major health problem in world that ultimate results in the liver cirrhosis and leads to carcinoma of hepatocellular components round the world. More than 185 million people were found to be infected with HCV. MicroRNAs are small oligonucleotide RNA having 18-22 nucleotides. Circulating mi-RNAs regulate the replication of HCV and HCV-induced liver fibrosis and HCC. By comparing the expression profiles of mi-RNAs of normal individuals with HCV infected patients, aberrant changes in expression of different mi-RNAs have been observed so it can be predicted that these mi-RNAs are associated with and play a central role in the hepatitis C infection and diseases associated with it. This review demonstrates the major role of circulatory microRNAs in the HCV and HCV associated ailments.

Entities:  

Keywords:  HCC; HCV; MiRNA; Pathogenecity

Year:  2017        PMID: 29291226      PMCID: PMC5747848          DOI: 10.1007/s13337-017-0407-3

Source DB:  PubMed          Journal:  Virusdisease        ISSN: 2347-3584


  81 in total

1.  Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR.

Authors:  J Robin Lytle; Therese A Yario; Joan A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

Review 2.  Hepatitis C treatment: an incipient therapeutic revolution.

Authors:  Andrew S deLemos; Raymond T Chung
Journal:  Trends Mol Med       Date:  2014-03-11       Impact factor: 11.951

3.  Re-evaluation of the roles of DROSHA, Export in 5, and DICER in microRNA biogenesis.

Authors:  Young-Kook Kim; Boseon Kim; V Narry Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

4.  Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.

Authors:  Shu-Hao Hsu; Bo Wang; Janaiah Kota; Jianhua Yu; Stefan Costinean; Huban Kutay; Lianbo Yu; Shoumei Bai; Krista La Perle; Raghu R Chivukula; Hsiaoyin Mao; Min Wei; K Reed Clark; Jerry R Mendell; Michael A Caligiuri; Samson T Jacob; Joshua T Mendell; Kalpana Ghoshal
Journal:  J Clin Invest       Date:  2012-07-23       Impact factor: 14.808

5.  Hepatitis C virus infection modulates expression of interferon stimulatory gene IFITM1 by upregulating miR-130A.

Authors:  Joydip Bhanja Chowdhury; Shubham Shrivastava; Robert Steele; Adrian M Di Bisceglie; Ranjit Ray; Ratna B Ray
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

Review 6.  The role of microRNAs in cholesterol efflux and hepatic lipid metabolism.

Authors:  Kathryn J Moore; Katey J Rayner; Yajaira Suárez; Carlos Fernández-Hernando
Journal:  Annu Rev Nutr       Date:  2011-08-21       Impact factor: 11.848

7.  Competing and noncompeting activities of miR-122 and the 5' exonuclease Xrn1 in regulation of hepatitis C virus replication.

Authors:  You Li; Takahiro Masaki; Daisuke Yamane; David R McGivern; Stanley M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

8.  Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.

Authors:  Junichi Takamizawa; Hiroyuki Konishi; Kiyoshi Yanagisawa; Shuta Tomida; Hirotaka Osada; Hideki Endoh; Tomoko Harano; Yasushi Yatabe; Masato Nagino; Yuji Nimura; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

9.  Control of mitogenic and motogenic pathways by miR-198, diminishing hepatoma cell growth and migration.

Authors:  Natalia Elfimova; Elisabeth Sievers; Hannah Eischeid; Monika Kwiecinski; Andrea Noetel; Heike Hunt; Diana Becker; Peter Frommolt; Maria Quasdorff; Hans Michael Steffen; Peter Nürnberg; Reinhard Büttner; Andreas Teufel; Hans-Peter Dienes; Uta Drebber; Margarete Odenthal
Journal:  Biochim Biophys Acta       Date:  2013-02-05

10.  Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha.

Authors:  Carolina Scagnolari; Pompea Zingariello; Jacopo Vecchiet; Carla Selvaggi; Delia Racciatti; Gloria Taliani; Elisabetta Riva; Eligio Pizzigallo; Guido Antonelli
Journal:  Virol J       Date:  2010-11-12       Impact factor: 4.099

View more
  3 in total

1.  Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.

Authors:  Pinar Uysal-Onganer; Stefania D'Alessio; Maria Mortoglou; Igor Kraev; Sigrun Lange
Journal:  Int J Mol Sci       Date:  2021-01-30       Impact factor: 5.923

2.  miR-155 regulates pro- and anti-inflammatory cytokine expression in human monocytes during chronic hepatitis C virus infection.

Authors:  Yun Zhou; Peixin Zhang; Xuyang Zheng; Chuantao Ye; Mengyuan Li; Peiyu Bian; Chao Fan; Ying Zhang
Journal:  Ann Transl Med       Date:  2021-11

3.  Nickel's Role in Pancreatic Ductal Adenocarcinoma: Potential Involvement of microRNAs.

Authors:  Maria Mortoglou; Luka Manić; Aleksandra Buha Djordjevic; Zorica Bulat; Vladimir Đorđević; Katherine Manis; Elizabeth Valle; Lauren York; David Wallace; Pinar Uysal-Onganer
Journal:  Toxics       Date:  2022-03-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.